Table 2.

Independent predictors of unfavorable outcome despite complete reperfusion.

Variable	Model 1		Model 2		Model 3		Model 4
	OR (95%CI)	P	OR (95%CI)	P	OR (95%CI)	P	OR (95%CI)	P
Age	1.059 (1.018-1.102)	0.004*	1.064 (1.021-1.108)	0.003*	1.052 (1.009-1.096)	0.017*	1.047 (1.005-1.092)	0.029*
DM	1.905 (0.654-5.549)	0.237	2.151 (0.725-6.385)	0.168	2.077 (0.691-6.241)	0.193	2.231 (0.737-6.752)	0.156
CAD	1.339 (0.483-3.713)	0.575	1.341 (0.484-3.716)	0.573	1.174 (0.408-3.379)	0.766	1.211 (0.418-3.512)	0.725
NIHSS	1.246 (1.121-1.385)	<0.001*	1.249 (1.120-1.391)	<0.001*	1.231 (1.104-1.372)	<0.001*	1.226 (1.098-1.367)	<0.001*
Good collaterals	0.161 (0.066-0.392)	<0.001*	0.166 (0.068-0.406)	<0.001*	0.158 (0.063-0.396)	<0.001*	0.135 (0.052-0.353)	<0.001*
Glucose	0.946 (0.817-1.096)	0.461	0.931 (0.801-1.082)	0.350	0.924 (0.790-1.080)	0.320	0.955 (0.822-1.110)	0.548
General anesthesia	4.507 (1.514-13.412)	0.007*	4.256 (1.423-12.733)	0.010*	4.211 (1.351-13.130)	0.013*	4.444 (1.434-13.768)	0.010*
NLR1	–	–	1.072 (0.995-1.154)	0.066	–	–	–	–
NLR2	–	–	–	–	1.070 (1.012-1.131)	0.017*	–	–
NLR3	–	–	–	–	–	–	1.129 (1.032-1.236)	0.008*

OR, odds ratio; CI, confidence interval; DM, diabetes mellitus; CAD, coronary artery disease; NIHSS, National Institutes of Health Stroke Scale; NLR, neutrophil to lymphocyte ratio

NLR1 were measured at admission;

NLR2 were measured within 24h after EVT;

NLR3 were measured at 3-7d after EVT.

*P<0.05.